Standard Dosage Range
Research dosing range: 20 IU (units) intramuscularly, once weekly
Educational reference only
Dosage by Use Case
Osteoporosis & Bone Pain
Long-term (years)
Administered intramuscularly. Primarily used in Japan. May be combined with bisphosphonates or other osteoporosis therapies.
Hypercalcemia
Short-term (days-weeks)
Administered intramuscularly. Dosage adjusted based on serum calcium levels. Monitor calcium frequently.
Paget's Disease
6-12 months
Administered intramuscularly. Used to reduce bone turnover and pain associated with Paget's disease.
Timing & Frequency
Elcatonin is typically administered once weekly. The timing of the injection is not critical, but consistency is recommended to maintain steady-state levels. Can be administered at any time of day.
Cycle Guidance
Elcatonin is typically used long-term for osteoporosis. For hypercalcemia, use is limited to the acute phase. For Paget's disease, courses of 6-12 months may be used. Cycling is not typically employed, but periodic monitoring for antibody development is recommended.
Reconstitution Reference
Quick reference for reconstituting Elcatonin. For custom vial sizes and concentrations, use the Reconstitution Calculator.
| Common Vial Size | Typically supplied as a pre-filled syringe or ampule containing 20 IU/mL. |
| BAC Water Volume | N/A - Supplied as a pre-mixed solution. |
| Concentration & Draw | 20 IU/mL (pre-mixed) |
| Storage | Refrigerate at 2–8°C. Protect from light. |
| Stability | Stable until expiry date when refrigerated. |
Frequently Asked Questions
What is the standard elcatonin dosage for osteoporosis?
How long can elcatonin be used for osteoporosis?
How is elcatonin administered?
Last updated: 2026-02-19